Inovio Pharmaceuticals (INO) said Thursday that it has priced an underwritten public offering of 12.5 million shares, Series A warrants to buy up to 12.5 million shares, and Series B warrants to buy up to 12.5 million shares at a combined price of $1.40 per share and Series A and Series B warrants, for expected gross proceeds of $17.5 million.

The underwriter was given an option for a 30-day period to buy up to 1.875 million additional shares of the company's common stock, Series A warrants to buy up to 1.875 million additional shares, and Series B warrants to buy up to 1.875 million additional shares, Inovio said.

The offering is expected to be completed on or about April 6, the company said.

Price: 1.19, Change: -0.56, Percent Change: -31.90